Rapid UTI test wins £8m Longitude Prize on Antimicrobial Resistance The winning test uses a urine sample on a smartphone-sized cartridge to identify the presence of a bacterial infection in 15 minutes and the antibiotic required within 45 minutes.…
Bariatric surgery more effective than GLP-1 agonist weight loss drugs, study finds Weight loss from bariatric surgery was maintained at approximately 25% for up to ten years after surgery, while patients who received GLP-1 receptor agonists regained 50% of the weight lost within one year of stopping treatment.…
Conservative Party pledges to expand Pharmacy First funding to £250m a year The Conservatives say they would expand the areas offered under Pharmacy First to include menopause support, contraception and treatment for chest infection.…
Combination treatment before surgery improves melanoma survival rates, study results show The 12-month event-free survival rate for patients with macroscopic stage III node-positive melanoma was 83.7% with the combination treatment, compared with 57.2% for adjuvant therapy alone.…
Diabetic ketoacidosis in adults: identification, diagnosis and management All healthcare professionals who support people with diabetes should be aware of this complex medical emergency so that they can recognise red flag symptoms.…
Pharmacists to be central in delivery of campaign to cut prescribing of high-risk pain medicines NHS Fife's 'Pain Talking' campaign is aimed at giving patients better control over chronic pain management and promoting non-medical treatment.…
Pregabalin prescribing increases by almost 25% since restrictions imposed Exclusive: Almost 670,000 patients in England were prescribed pregabalin when it was first reclassified in 2018/2019, compared with more than 820,000 patients in 2023/2024.…
Stopping antidepressants causes withdrawal symptoms in 15% of patients, meta-analysis finds Researchers estimated one in six to seven people will experience withdrawal symptoms when stopping antidepressants.…
‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing? The takeover of inhaler company Vectura by tobacco firm Philip Morris International has stirred up debate and controversy, with experts raising questions around whether the NHS is doing enough to make the connection clear to prescribers and patients.…
NHS spends £430m on inhalers linked to Philip Morris since Vectura takeover Exclusive: An analysis by The Pharmaceutical Journal of prescribing data has raised questions from experts on whether more should be done to highlight the inhalers‘ links to the tobacco company.…
